Clinical Trial Update: Evaluate the Efficacy of Oxybutynin Chloride in Patients With Primary Hyperhidrosis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating oxybutynin chloride for primary hyperhidrosis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperhidrosis

Drugs mentioned

• Oxybutynin chloride (Oxybutynin chloride)

Snippet

Sponsor: Cristália Produtos Químicos Farmacêuticos Ltda. | Conditions: Hyperhidrosis | Phase 3 | Status: WITHDRAWN